1. Approach to a child with
bleeding disorder
DR NEHAL SHAH
PGR peads ii
Services hospital lahore
2. Normal hemostasis
is to arrest bleeding by formation of a thrombus
Functions
• To maintain the blood in fluid state
• To prevent clots in intact vessels
• To arrest bleeding in injured vessels
• Components
Blood vessels
Platelets
Plasma coagulation factors
Fibrinolytic system
3. Bleeding or hemorrhaging, is the escape of blood from the circulatory
system.
Bleeding can occur
• – internally
• – externally
bleeding is due to a functional impairment of the normal hemostatic
process.
4. INJURY
VESSEL WALL+PLATELET
FORMATION OF PLT PLUG
ACTIVATION OF PLASMA COAGULATION FACTORS
FORMATION OF STABLE FIBRIN CLOT
DISSOLUTION OF FIBRIN CLOT BY FIBRINOLYSIS
11. INHERITED DISORDERS
• Early age of presentation
• Family history positive
• More severe
• Bleeding is the dominant feature
• Single factor defect
ACQUIRED DISORDERS
• Later age of presentation
• Family history usually negative
• Less severe
• Clinical picture is dominated by
the
• underlying disorder e g. DIC
• Multiple hemostatic defect
13. History
Site of bleeding,
The severity and duration of hemorrhage, and
The age at symptom onset.
• –Spontaneous or after trauma
• – Previous personal or family history of similar problems?
• – Recent transfusion
14. • A history of anemia and/or previous treatment with iron
• Joint pain, swelling or limitation of movement
• Bleeding from umbilical stump
• Previous surgery or significant dental procedures,
• was there any increased bleeding?
• Delayed or slow healing of superficial injuries
15. • Menstrual history (in post pubertal females)
• Medications ( NSAIDs, anticonvulsant , antihistamin, or herbal
medications cause thrombocytopenia
• Nutritional Hx to assess the likelihood of vt k & C deficiency
16. FAMILY HISTORY
consanguinity >> autosomal recessive bleeding disorder
Known bleeding disorder or other heritable medical disorder
that may predispose to bruising (eg, Ehlers-Danlos syndrome).
• Male relatives affected (Hemophilia, X-linked Recessive trait)
• Female relatives - Menstrual and Obstetric Hx
• males and females affected >>an autosomal disorder such as
von Willebrand factor deficiency
• autosomal dominant traits such as hereditary hemorrhagic telangiectasia
17. Epistaxis-symptom of platelet disorders & vWD
Gingival hemorrhage- platelet disorders & vWD
Oral mucous membrane bleeding- severe thrombocytopenia
Skin hemorrhage ( petechiae and ecchymoses)-
common manifestations of hemostatic & nonhemostatic disorders
Hemarthroses- hallmark abnormality in the hemophilia’s, severe factor
VII deficiency
18. • If child bleeds from injury ,does the bleeding stop and resume(DIC)
• If child bleeds from superficial cut with profuse bleed(platelet
disorder
• If fever and neurological manifestations(Meningococcemia)
• If history of viral prodrome (ITP/HUS)
• If patient taking aspirin , ibuprofen,antibiotics (Drug related purpura)
• If patient is neonate , and mother took phenytoin ( Vit K Deficiency)
20. The examination should determine the presence of :
• petechiae,
• ecchymosis,
• hematomas,
• hemarthroses,
• mucous membrane bleeding.
21. Look for hepatosplenomegaly
Do a rectal exam for evidence of GI bleeding
Look for physical signs and symptoms of diseases related to capillary
fragility:
Lymphadenopathy + hepatosplenomegaly
• Leukemia
• Lymphoma
• Infection
22. • Individuals with disorders of the collagen matrix and vessel wall may
have loose joints and lax skin associated with easy bruising (Ehlers-
Danlos syndrome).
• Deep Bleed (muscle or joints) Individuals with a clotting factor
deficiency of factor VIII or IX (hemophilia A or B)
• Symmetric Purpura on Legs and buttocks( Henoch–schonlein
Purpura)
• Ecchymotic Lesions Extensive and in various stages of revolutions
(Physical Abuse)
23. manifestations in thrombocytopenia
• Petechiae
• Bruises or purpura
• Bleeding from mucous membranes: epistaxis, gingival bleeding
• Acute gastrointestinal bleeding
• Hematuria
• Acute CNS hemorrhage: the rarest consequence of low platelets
24. manifestations in hemophilia
• Bleeding In soft Tissue ,GI ,Hip, elbow , and ankle Joint.
• Spontaneous joint bleeding occur when child begin to walk
• Intracranial hemorrhage uncommon (important
cause of death)
• Petechiae usually do not occur in patients with
hemophilia
26. Lab investigations
• Full blood count and blood film
• Bleeding time
• Prothrombin time with INR – measure factors II, V,VII, X.
• Activated Partial thromboplastin time measures II, V, VIII, IX, X, XI and
XII.
• Mixing studies
• Thrombin Time
• Quantitative fibrinogen assay
• D-Dimers
• Biochemical Screen for renal and Liver function tests
• Platelet aggregation studies
27. 1st line investigation
• Test for platelets
• Platelet count
• Bleeding Time(BT)
• Test for coagulation factors
• Prothrombin Time(PT)
• Activated Partial Thromboplastin Time(aPTT)
• Thrombin Time(TT)
• Fibrinogen assay
28. Bleeding Time (BT)
Significance
• Assess primary haemostatic defect
• vessel wall or platelet interaction.
• Dependent on adequate functioning of
– Platelets
– Blood Vessels.
Range
4-8 min
30. Prothrombin Time(PT)
Reflects overall activity of the Extrinsic Pathway.
Most sensitive to changes in Factor V,VII,X.
Lesser to Factor I & II.
Normal range
12-15 seconds
32. Activated Partial Thromboplastin Time (aPTT)
Significance
• Reflects activity of Intrinsic Pathway.
• Sensitive to changes in Factor VIII,IX,XI,XII.
• Also sensitive to heparin & circulating anticoagulants.
• The test measures the clotting time of plasma after the
activation of contact
Normal range
26 to 40 seconds.
33. Causes of prolonged aPTT
• Deficiency of Factor VIII (Haemophilia A).
• Deficiency of Factor IX (Haemophilia B).
• Heparin therapy.
• Circulating anticoagulants.
• Liver disease.
34. Thrombin Time(TT)
Significance
• Asses the final step of coagulation, i.e. conversion of fibrinogen to
• fibrin in presence of thrombin.
• Bypasses Extrinsic & Intrinsic pathway.
Principle
• Thrombin is added to plasma and the clotting time is measured.
• TT is affected by the concentration and reaction
of fibrinogen and by the presence of inhibitory substances.
• Normal range
• • 15–19 sec, Times of 20 s and longer are definitely abnormal
35. Causes of prolonged TT
Disorders of fibrinogen-
• Afibrinogenaemia.
• Hypofibrinogenaemia
• Dysfibrinogenaemia.
Liver disease.
heparin therapy
36. 2nd line investigations
Carried out with each of the patterns of abnormalities in first line tests
• Mixing test.
• Factor VII assay.
• Liver function test.
37. • Mixing test
• – If prolong. PT, PTT, or TT
Normal plasma + patient's plasma, and the PT or PTT is repeated.
Correction of PT or PTT => def. of a clotting factor
(because a 50% level of individual clotting proteins is sufficient to
produce normal PT or PTT)
38. • If the clotting time is not corrected or only partially corrected, an
inhibitor
• – chemical similar to heparin that delays coagulation or
• – an antibody directed against a specific clotting factor.(MC- VIII, IX, or
XI, may be present) or the phospholipids used in clotting tests is
usually present
39.
40.
41.
42.
43.
44.
45. Treament OF bleeding disorders
ITP
Intravenous immunoglobulins
Steroids
Anti D immunoglobulins
platelet transfusion (for life threatening hemorrhage)
56. Easy bruising- Ehlers-Danlos syndrome
Excessive bleeding in response to razor nicks =platelet disorders or von
Will brand disease.
Hemoptysis- haemostatic disorders in URT.
Hematemesis- haemostatic disorders in upper GI
Hematuria- hemophilia's & haemostatic disorders
Rectal bleeding -in normal-hemorrhoids- von Willebrand disease and
platelet disorders
Melena
Postpartum hemorrhage -DIC
Habitual spontaneous abortions- quantitative or
qualitative abnormality of fibrinogen.